Symbiox Investment & Trading Co. Ltd. - Research Center
539278 SYMBIOX Group (X) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
| 31.29 |
31.29 |
31.29 |
31.29 |
31.29 |
Share application money
Preference share capital
Reserves & surplus
| 0.44 |
0.24 |
0.04 |
-0.12 |
-0.33 |
Secured loans
Unsecured loans
Total
| 31.72 |
31.53 |
31.32 |
31.17 |
30.96 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
| 12.71 |
9.88 |
12.72 |
17.54 |
17.94 |
Current assets, loans & advances
| 19.24 |
21.94 |
20.04 |
14.27 |
15.31 |
Less : current liabilities & provisions
Total net current assets
| 18.99 |
21.64 |
18.60 |
13.62 |
13.02 |
Miscellaneous expenses not written
Total
| 31.72 |
31.53 |
31.32 |
31.17 |
30.96 |
Book value of unquoted investments
| 12.71 |
9.88 |
12.72 |
17.54 |
17.94 |
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
| 312.87 |
312.87 |
312.87 |
312.87 |
312.87 |